DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).
How do you administer a Defibrotide?
The recommended dosage of DEFITELIO for adult and pediatric patients is 6.25 mg/kg every 6 hours given as a 2- hour intravenous infusion. The dose should be based on patient’s baseline body weight, defined as the patient’s weight prior to the preparative regimen for HSCT. Administer DEFITELIO for a minimum of 21 days.
Does defibrotide work?
Defibrotide works by increasing the breakdown of clots in the blood. Defibrotide is used to treat severe veno-occlusive disease (VOD) in adults and children who have undergone chemotherapy and a stem-cell transplant.
What type of drug is defibrotide?
Defibrotide injection is in a class of medications called antithrombotic agents. It works by preventing the formation of blood clots.
How long does it take for Defibrotide to work?
Defibrotide: administration, duration of use, actual given dose. The median delay to start DF was 1 day after the diagnosis of VOD (range 0–12 days). The median duration of treatment with DF was 17 days (range 1–83 days).
Is busulfan a chemo drug?
Drug type: Busulfan is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. This medication is classified as an “alkylating agent.” (For more detail, see “How this drug works” section below).
What is the basic ring of busulfan?
Busulfan is a methanesulfonate ester that is butane-1,4-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups. An alkylating antineoplastic agent, it is used for the treatment of chronic myeloid leukemia (although it has been largely replaced by newer drugs).
